PDS TM
Stakeholder participation depends on country-specific regulations
Manufacturers of pharmaceutical products & medical technologies:
- Detail the latest therapies employing AI, XR and metaverse technologies that engage the user
- Economise on the budget for representative salaries, travel, offices, hospitality and lobbying
- Remotely penetrate new markets and expand sales
- Save lives and protect revenues simultaneously by eliminating fake and substandard imitations of trademarked and patented products in poorly regulated markets
- Improve products by accessing anonymised feedback on their effectiveness by stakeholders where country regulations permit
Health Care Professionals (HCPs):
- Engage with the latest pharmaceutical products and medical technologies at one’s convenience resulting in cutting-edge therapies and treatments for patients
- Save valuable time by avoiding slower and traditional learning methods currently used by manufacturer representatives
Patients:
Become better informed on the latest pharmaceutical products and medical technologies towards high quality health for all
Pharmacies & Vendors:
Immerse in the latest pharmaceutical products and medical technologies to buy stock, distribute, retail and dispense prescriptions and OTC (Over-the-Counter) products to patients and hospitals
Health Care ADMINISTRATORS (HCAs):
- Compare and procure the latest and ‘value-for-money’ pharmaceutical products and medical technologies for hospitals
- Save valuable time by avoiding slower and traditional learning methods currently used by manufacturer representatives
Health Insurers:
Quickly learn about the latest pharmaceutical products and medical technologies to offer better-value and better-targeted insurance packages to patients
Regulators & law makers:
Speed-up approvals of drugs and technologies, and improve policies and regulations by learning through immersion in the metaverse